There is another angle re Merck to become CYDY'
Post# of 158133

CYDY's parent or partner :
Reading two boards about Northwest Bioscience (NWBO)
regularly and intensively (guess : Am I invested there ?) both boards are
fully convinced that M. will buy out NWBO.
With the same conviction this board hopes that M. will buy CYDY.
Apart from the M&A-issue there is an important scientific / medical question :
Which company with their products and strategies (CYDY or NWBO) would
make much more sense, would be the better fit, to Merck's existing and
future portfolio ?

